Haemorrhagic rectocolitis is an inflammatory bowel disease that continuously affects the rectum and colon, with lesions that extend variably from the rectum into the upstream colon. This disease requires repeated assessment of both clinical activity (transcribed by the clinical Mayo score) and endoscopic activity. ACCEPT study showed that the acceptability of rectosigmoidoscopy is low, and the main determinants of this low acceptability were pain and bloating (51%) and embarrassment during the examination (30%).
Virtual reality headsets has analgesic and anxiolytic properties, thanks to specially designed virtual environments that apply different principles such as medical hypnosis, music therapy and cardiac coherence to enhance therapeutic action.
The aim of our project is to study the benefit of medical hypnosis provided by the use of a virtual reality headset in terms of tolerance of lower digestive endoscopy in patients with ulcerative colitis.
Patients aged 18 or over with UC in the active phase or in remission of their disease
Patient who has already undergone rectosigmoidoscopy without general anaesthetic
Patient requiring rectosigmoidoscopy (with colonoscope and air insufflation) as part of routine care
Patient able to follow the Clinical Investigation protocol and having given written informed consent to participate
Patients with Crohn disease or indeterminate colitis
Patients hospitalised with severe acute colitis, as defined by the truelove criteria.
Patients with a stoma in place or with a history of colorectal resection.
Psychotic patients or patients diagnosed with psychiatric disorders
Parallel
Virtual reality headset
DeviceUse of a virtual reality headset during rectosigmoidoscopy
Pain intensity measured on a visual analogue scale
Pain intensity measured on a visual analogue scale (VAS) ranging from 0 (no pain) to 10 (maximum intolerable pain) immediately after the examination.
Click on the lead sponsor to view all of their trials.
